The following section summarizes insights on 10X Genomics Inc's Net Debt / Total Capital:
March 28, 2025: -
Performance Summary
10X Genomics's latest twelve months net debt / total capital is -25.2%
10X Genomics's net debt / total capital for fiscal years ending December 2020 to 2024 averaged -9.0%.
10X Genomics's operated at median net debt / total capital of -4.6% from fiscal years ending December 2020 to 2024.
Looking back at the last 5 years, 10X Genomics's net debt / total capital peaked in December 2021 at -3.1%.
10X Genomics's net debt / total capital hit its 5-year low in December 2024 of -25.2%.
10X Genomics's net debt / total capital decreased in 2022 (-8.3%, +168.2%) and 2024 (-25.2%, +554.5%) and increased in 2020 (-4.6%, -14.4%), 2021 (-3.1%, -32.7%) and 2023 (-3.8%, -53.9%).
A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus ...
Definition of Net Debt / Total Capital
Hide this widget
A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus cash and short-term investments.
Press space bar to start a drag.
When dragging you can use the arrow keys to move the item around and escape to cancel.
Some screen readers may require you to be in focus mode or to use your pass through key